Trial Outcomes & Findings for Cognition and Psychotherapy in PTSD (NCT NCT03641924)

NCT ID: NCT03641924

Last Updated: 2025-05-09

Results Overview

PTSD Symptoms. The range of the scale is from 0 (no symptoms) to 80 (maximal symptoms). Higher scores corresponds to more symptoms.

Recruitment status

COMPLETED

Target enrollment

110 participants

Primary outcome timeframe

Change from baseline to 12 weeks

Results posted on

2025-05-09

Participant Flow

28 participants either did not meet criteria for PTSD after a structured assessment (n=19), met criteria for a comorbid disorder that was exclusionary (n=4), or were lost to follow-up before completing baseline assessments.

Participant milestones

Participant milestones
Measure
Posttraumatic Stress Disorder (PTSD)
Veterans diagnosed with DSM-V PTSD Cognitive Processing Therapy: Cognitive Processing Therapy is an evidence-based psychotherapy for PTSD.
Overall Study
STARTED
110
Overall Study
Received Intervention
94
Overall Study
COMPLETED
58
Overall Study
NOT COMPLETED
52

Reasons for withdrawal

Reasons for withdrawal
Measure
Posttraumatic Stress Disorder (PTSD)
Veterans diagnosed with DSM-V PTSD Cognitive Processing Therapy: Cognitive Processing Therapy is an evidence-based psychotherapy for PTSD.
Overall Study
Withdrawal by Subject
26
Overall Study
Lost to Follow-up
16
Overall Study
Protocol Violation
10

Baseline Characteristics

Cognition and Psychotherapy in PTSD

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Veterans With PTSD
n=94 Participants
Veterans with DSM-5 PTSD as assessed with the Clinician Administered PTSD Scale
Age, Continuous
45 years
STANDARD_DEVIATION 12 • n=5 Participants
Sex: Female, Male
Female
30 Participants
n=5 Participants
Sex: Female, Male
Male
64 Participants
n=5 Participants
Race (NIH/OMB)
American Indian or Alaska Native
1 Participants
n=5 Participants
Race (NIH/OMB)
Asian
4 Participants
n=5 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
2 Participants
n=5 Participants
Race (NIH/OMB)
Black or African American
40 Participants
n=5 Participants
Race (NIH/OMB)
White
45 Participants
n=5 Participants
Race (NIH/OMB)
More than one race
2 Participants
n=5 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants
n=5 Participants
Region of Enrollment
United States
94 Participants
n=5 Participants
Mild Traumatic Brain Injury (TBI)
49 Participants
n=5 Participants
Moderate TBI
7 Participants
n=5 Participants
PTSD Checklist (PCL-5)
45 units on a scale
STANDARD_DEVIATION 11 • n=5 Participants

PRIMARY outcome

Timeframe: Change from baseline to 12 weeks

Population: Based on baseline memory scores

PTSD Symptoms. The range of the scale is from 0 (no symptoms) to 80 (maximal symptoms). Higher scores corresponds to more symptoms.

Outcome measures

Outcome measures
Measure
Low Memory
n=31 Participants
Bottom tertile of memory performance
Medium Memory
n=32 Participants
Middle tertile of memory performance
High Memory
n=31 Participants
Top tertile of memory performance
Change in PTSD Checklist (PCL-5)
9.25 change in units on a scale
Standard Deviation 20.37
11.94 change in units on a scale
Standard Deviation 15.93
15.91 change in units on a scale
Standard Deviation 15.10

PRIMARY outcome

Timeframe: Change from baseline to 12 weeks

Population: Groups based on baseline memory scores

Functional Status. Scored 1-5, with higher scores indicating worse functioning.

Outcome measures

Outcome measures
Measure
Low Memory
n=30 Participants
Bottom tertile of memory performance
Medium Memory
n=31 Participants
Middle tertile of memory performance
High Memory
n=30 Participants
Top tertile of memory performance
Social Adjustment Scale-Self Report (SAS-SR)
0.14 change in units on a scale
Standard Deviation 0.56
0.10 change in units on a scale
Standard Deviation 0.41
0.38 change in units on a scale
Standard Deviation 0.42

SECONDARY outcome

Timeframe: Change from baseline to 12 weeks

Population: Based on baseline memory scores

Mental Health-Related Quality of Life. Scores range from 0-100; higher values indicate better mental health-related quality of life.

Outcome measures

Outcome measures
Measure
Low Memory
n=30 Participants
Bottom tertile of memory performance
Medium Memory
n=31 Participants
Middle tertile of memory performance
High Memory
n=30 Participants
Top tertile of memory performance
Veterans RAND 12 Item Health Survey Mental Component Summary (VR-12 MCS)
1.26 change in units on a scale
Standard Deviation 7.95
0.32 change in units on a scale
Standard Deviation 9.05
0.39 change in units on a scale
Standard Deviation 6.11

Adverse Events

PTSD

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Dr. James Cobb Scott

Corporal Michael J. Crescenz VAMC

Phone: 2158235800

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place